Gender bias in drug dosage trials and overmedicated women


A new study from the journal Biology of Sex Differences found an association between sex biases in drug dosage trials and the overmedication of women.

According to investigators, women are more likely than men to experience adverse drug reactions from medications, as clinical trials have historically focused on men.

In the August issue of Contemporary OB/GYN, Editor-in-Chief Dr. Catherine Y. Spong discussed the ways in which women’s health research has and continues to be marginalized. Read her full editorial here.

“Only in 1993, with the passage of the National Institutes of Health Revitalization Act, were women mandated to be included in NIH-funded research,” wrote Dr. Spong.

For additional details on the study’s findings, visit our sister publication, Drug Topics.

Related Videos
Discussing PCOS: misconceptions, management, encouragement | Image Credit:
The importance of diversity in obstetrics | Image Credit: ©
Study confirms efficacy of JADA against postpartum bleeding | Image Credit: © Amy Taneja MD - © Amy Taneja MD -
Matthew Zerden, MD
John Stanley, MD
Marci Bowers, MD | Image Credit:
Sean Esplin, MD
Jermaine Gray
Related Content
© 2023 MJH Life Sciences

All rights reserved.